Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Rotator Cuff Syndrome and Bursitis: A Double Blind, Controlled Trial to Assess the Efficacy and Safety of Traumeel® S Injection Versus Corticosteroid Injections and Versus Placebo

NCT01702233 is registered in ClinicalTrials.gov with Biologische Heilmittel Heel GmbH as lead sponsor.

NCT NCT01702233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01702233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Rotator Cuff Syndrome and Bursitis: A Double Blind, Controlled Trial to Assess the Efficacy and Safety of Traumeel® S Injection Versus Corticosteroid Injections and Versus Placebo
Lead sponsor
Biologische Heilmittel Heel GmbH
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2013
Completion date
June 30, 2014
Enrollment
175 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rotator cuff syndrome, shoulder bursitis